Notably, IPA-based analysis of DEG in CM from SF3B1wt LR-MDS patients, of whom 2 out of 3 carried somatic mutations in TET2, brought to the fore different inflammatory pathways predicted to be more active compared to HD (Fig. 2B). The gene discussed is TET2; the disease is myelodysplastic syndrome.